D. Raufaste

发表

Binding of [3H] SR 49059, a potent nonpeptide vasopressin V1a antagonist, to rat and human liver membranes.

G. Le Fur, C. Serradeil-Le Gal, J. Maffrand, 1994, Biochemical and biophysical research communications.

Binding properties of a selective tritiated vasopressin V2 receptor antagonist, [H]-SR 121463.

G. Guillon, C. Serradeil-Le Gal, M. Pascal, 2000, Kidney international.

Characterization and localization of leptin receptors in the rat kidney

J. Maffrand, G. Le Fur, C. Serradeil-Le Gal, 1997, FEBS letters.

Endothelin action in rat liver. Receptors, free Ca2+ oscillations, and activation of glycogenolysis.

P. Cobbold, J. Hanoune, S. Lotersztajn, 1991, The Journal of clinical investigation.

Growth inhibitory properties of endothelin-1 in activated human hepatic stellate cells: a cyclic adenosine monophosphate-mediated pathway. Inhibition of both extracellular signal-regulated kinase and c-Jun kinase and upregulation of endothelin B receptors.

D. Brenner, D. Dhumeaux, A. Mallat, 1996, The Journal of clinical investigation.

Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells. An endothelin B receptor-mediated pathway.

C. S. Gal, D. Dhumeaux, A. Mallat, 1995, The Journal of clinical investigation.

V2 receptor antagonism of DDAVP-induced release of hemostasis factors in conscious dogs.

J. Herbert, C. Serradeil-Le Gal, P. Hoffmann, 1997, The Journal of pharmacology and experimental therapeutics.

Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.

C. S. Gal, G. Fur, L. Bankir, 1996, The Journal of clinical investigation.

Biological effects of sarafotoxin in rat liver.

J. Hanoune, S. Lotersztajn, C. Serradeil-Le Gal, 1992, Biochemical pharmacology.

Autoradiographic localization of vasopressin V1a receptors in the rat kidney using [3H]-SR 49059.

G. Le Fur, C. Serradeil-Le Gal, J. Maffrand, 1996, Kidney international.

Effect of a new, potent, non-peptide V1a vasopressin antagonist, SR 49059, on the binding and the mitogenic activity of vasopressin on Swiss 3T3 cells.

P. Casellas, G. Le Fur, C. Serradeil-Le Gal, 1994, Biochemical pharmacology.

Biological characterization of rodent and human vasopressin V1b receptors using SSR-149415, a nonpeptide V1b receptor ligand.

J. Wagnon, C. Serradeil-Le Gal, M. Pascal, 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

Comparative pharmacology of bovine, human and rat vasopressin receptor isoforms.

G. Guillon, C. Serradeil-Le Gal, M. Trueba, 2004, European journal of pharmacology.

Vasopressin receptors in human adrenal medulla and pheochromocytoma.

G. Guillon, C. Breton, E. Grazzini, 1999, The Journal of clinical endocrinology and metabolism.

Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells.

J. Herbert, G. Le Fur, P. Schaeffer, 1995, The American journal of physiology.